Abstract
In a group of 110 dialysis patients, 21% had anti-HCV antibodies. Statistical differences were noted according to method and duration of dialysis as well as the presence of further risk factors.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Dialysis / adverse effects*
-
Female
-
Hepatitis C / complications
-
Hepatitis C / epidemiology*
-
Humans
-
Italy / epidemiology
-
Male
-
Middle Aged
-
Risk Factors
-
Time Factors